Roche Extends Expiration of Tender Offer for Foundation Medicine Shares | GenomeWeb

NEW YORK(GenomeWeb) – Roche today said it has extended the expiration of its tender offer for common shares of Foundation Medicine to midnight EST at the end of the day April 6. 

The tender offer for 15,604,288 shares of Foundation's stock at $50 per share is part of a $1.2 billion stake that Roche plans to take in the Cambridge, Mass.-based cancer molecular diagnostics firm. All other terms and conditions of the tender offer remain the same.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.